2022

Artificial Intelligence Act – A long awaited report surfaces

EU rushing WTO members to adopt weak waiver text

Risks and Harms from Health-related AI

Make good on access to medicine commitments HAI asks new Dutch Health Minister

2021

Transparency: Bringing the Issue to Life

Working with the European Parliament

WHO Recommends Malaria Vaccine for Use

COVID-19: European Commission gives lacklustre response to legitimate civil society concerns

European Commission is offering no meaningful solutions for equitable access

Clinical Trial Data and the Risk of Bias

Getting Hack to Reality

C-TAP has not (yet) lived up to high expectations

A Pandemic Response Lacking Moral Leadership

MPs and MEPs Call for TRIPS Waiver

Over 100 MEPs call for a TRIPS Waiver

Access to Medicines in Europe

2020

There is no UHC without Universal Medicines Coverage

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

COVID-19 risks turning back the clock on years of essential development work

Reflections on the World Health Assembly

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

In defence of WHO

HAI Follows Dutch Government Advice in Response to COVID-19

HAI Recognised for Commitment to Gender Equality

2019

A Momentous Week for Access to Medicines

Welcome to the new look website!